AbbVie
ABBV
3,757 hedge funds and large institutions have $227B invested in AbbVie in 2024 Q4 according to their latest regulatory filings, with 444 funds opening new positions, 1,503 increasing their positions, 1,413 reducing their positions, and 131 closing their positions.
239% more first-time investments, than exits
New positions opened: 444 | Existing positions closed: 131
34% more capital inflows, than outflows
Capital inflows: $14B | Capital outflows: $10.4B
7% more funds holding
Funds holding: 3,509 → 3,757 (+248)
6% more call options, than puts
Call options by funds: $3.18B | Put options by funds: $2.99B
6% more repeat investments, than reductions
Existing positions increased: 1,503 | Existing positions reduced: 1,413
0.62% more ownership
Funds ownership: 71.69% → 72.31% (+0.62%)
19% less funds holding in top 10
Funds holding in top 10: 208 → 168 (-40)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.11B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$821M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$806M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$662M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$620M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$1.52B |
| 2 |
Janus Henderson Group
London,
|
-$1.07B |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$857M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$762M |
| 5 |
Bank of New York Mellon
New York
|
-$625M |
ABBV Hedge Fund Activity: Q4 2024 in Review
3,757 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q4 2024, worth a combined $227B — down 9.1% from $250B a quarter earlier.
Buyers outnumbered sellers: 444 funds opened new ABBV positions and 131 closed out — a net gain of 313 holders — while 1,503 added to existing stakes and 1,413 trimmed.
The largest buyer was BlackRock, adding an estimated $1.11B. The largest seller was Capital International Investors, cutting an estimated $1.52B.
- 3,757 institutional investors held AbbVie (ABBV) as of Q4 2024, up from 3,509 in Q3 2024.
- Funds reported $227B of AbbVie stock for Q4 2024, down 9.1% quarter-over-quarter.
- 444 funds opened new AbbVie positions in Q4 2024 and 131 closed out, a net change of +313 holders.
- The largest AbbVie buyer in Q4 2024 was BlackRock, an estimated $1.11B added.
- The largest AbbVie seller in Q4 2024 was Capital International Investors, an estimated $1.52B sold.
Based on aggregated 13F filings for Q4 2024.